name:-0.30571985244751
name:-0.22121000289917
name:-0.0021781921386719
Santaris Pharma A/S Patent Filings

Santaris Pharma A/S

Patent Applications and Registrations

Patent applications and USPTO patent grants for Santaris Pharma A/S.The latest application filed is for "potent lna oligonucleotides for the inhibition of hif-1a expression".

Company Profile
2.49.63
  • Santaris Pharma A/S - Horsholm N/A DK
  • Santaris Pharma A/S - Hoersholm N/A DK
  • Santaris Pharma A/S - Hersholm DK
  • Santaris Pharma A/S; - Horsholm DK
  • Santaris Pharma A/S -
  • Santaris Pharma A/S - DK DK
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
Potent LNA oligonucleotides for the inhibition of HIF-1a expression
Grant 9,447,138 - Westergaard , et al. September 20, 2
2016-09-20
Antisense design
Grant 9,428,534 - Christensen , et al. August 30, 2
2016-08-30
Potent Lna Oligonucleotides For The Inhibition Of Hif-1a Expression
App 20160229883 - Westergaard; Majken ;   et al.
2016-08-11
Short interfering RNA (siRNA) analogues
Grant 9,297,010 - Elmen , et al. March 29, 2
2016-03-29
Compositions and Methods for Modulation of ATXN3 Expression
App 20150315595 - Uzcategui; Nathalie ;   et al.
2015-11-05
MICROMIRs
App 20150299699 - OBAD; Susanna ;   et al.
2015-10-22
Anti Apob Antisense Conjugate Compounds
App 20150291958 - Albaek; Nanna ;   et al.
2015-10-15
Pharmaceutical composition comprising anti-miRNA antisense oligonucleotides
Grant 9,133,455 - Elmen , et al. September 15, 2
2015-09-15
Splice Switching Oligomers for TNF Superfamily Receptors and Their Use in Treatment of Disease
App 20150252371 - Sazani; Peter L. ;   et al.
2015-09-10
Amino-LNA, thio-LNA and alpha-L-oxy-LN
Grant 9,045,518 - Christensen , et al. June 2, 2
2015-06-02
RNA antagonists targeting GLI2 for the treatment of leukemia
Grant 9,040,493 - Zhang , et al. May 26, 2
2015-05-26
MicromiRs
Grant 8,906,871 - Obad , et al. December 9, 2
2014-12-09
Splice Switching Oligomers For Tnf Superfamily Receptors And Their Use In Treatment Of Disease
App 20140357849 - Orum; Henrik ;   et al.
2014-12-04
Compounds For The Modulation Of Smn2 Splicing
App 20140343127 - Kammler; Susanne
2014-11-20
Pharmaceutical Composition Comprising Anti-miRNA Antisense Oligonucleotides
App 20140329883 - ELMEN; Joacim ;   et al.
2014-11-06
Compounds For The Modulation Of Beta-catenin Expression And Uses Thereof
App 20140323557 - Dumble; Melissa ;   et al.
2014-10-30
Antisense Design
App 20140296502 - Christensen; Signe M. ;   et al.
2014-10-02
Antisense Design
App 20140288290 - Christensen; Signe M. ;   et al.
2014-09-25
Process
App 20140288299 - Meldgaard; Michael ;   et al.
2014-09-25
Oligomeric compounds for the modulation of HIF-1A expression
Grant 8,785,617 - Thrue , et al. July 22, 2
2014-07-22
Amino-lna, Thio-lna And Alpha-l-oxy-ln
App 20140194614 - Christensen; Signe M. ;   et al.
2014-07-10
Amino-lna, Thio-lna And Alpha-l-oxy-ln
App 20140128586 - Christensen; Signe M. ;   et al.
2014-05-08
Antisense Design
App 20140128591 - Christensen; Signe M. ;   et al.
2014-05-08
Bicyclonucleoside and oligonucleotide analogues
Grant RE44,779 - Imanishi , et al. February 25, 2
2014-02-25
Short interfering RNA (siRNA) analogues
Grant 8,653,252 - Elmen , et al. February 18, 2
2014-02-18
Methods For Treating Androgen Receptor Dependent Disorders Including Cancers
App 20140031409 - Worm; Jesper ;   et al.
2014-01-30
Short oligomer antagonist compounds for the modulation of target mRNA
Grant 8,580,756 - Hansen , et al. November 12, 2
2013-11-12
Antisense oligomers targeting PCSK9
Grant 8,563,528 - Straarup , et al. October 22, 2
2013-10-22
Synthesis of locked nucleic acid derivatives
Grant 8,492,390 - Detlef Sorensen , et al. July 23, 2
2013-07-23
Micro-RNA mediated modulation of colony stimulating factors
Grant 8,492,357 - Worm , et al. July 23, 2
2013-07-23
RNA antagonist compounds for the inhibition of Apo-B100 expression
Grant 8,470,791 - Hansen , et al. June 25, 2
2013-06-25
RNA antagonist compounds for the modulation of PIK3CA expression
Grant 8,450,291 - Hedtjarn May 28, 2
2013-05-28
Methods for treating androgen receptor dependent disorders including cancers
Grant 8,450,290 - Worm , et al. May 28, 2
2013-05-28
RNA antagonists targeting Hsp27
Grant 8,440,809 - Worm May 14, 2
2013-05-14
Combination treatment for the treatment of hepatitis C virus infection
Grant 8,440,637 - Elmen May 14, 2
2013-05-14
Oligomeric Compounds For The Modulation Of Hif-1a Expression
App 20130116309 - Thrue; Charlotte Albaek ;   et al.
2013-05-09
Potent LNA oligonucleotides for the inhibition of HIF-1A expression
Grant 8,410,071 - Westergaard , et al. April 2, 2
2013-04-02
Pharmaceutical compositions for treatment of MicroRNA related diseases
Grant 8,404,659 - Kauppinen , et al. March 26, 2
2013-03-26
Pharmaceutical compositions for treatment of microRNA related diseases
Grant 8,361,980 - Kauppinen , et al. January 29, 2
2013-01-29
Lna Oligonucleotides And The Treatment Of Cancer
App 20120322848 - Rosenbohm; Christoph ;   et al.
2012-12-20
Small internally segmented interfering RNA
Grant 8,329,888 - Wengel , et al. December 11, 2
2012-12-11
Rna Antagonist Compounds For The Modulation Of Her3
App 20120295955 - Hedtjarn; Maj
2012-11-22
Oligomeric Compounds For The Modultion of HIF-1A Expression
App 20120270924 - Thrue; Charlotte Alb.ae butted.k ;   et al.
2012-10-25
MicroRNAs
Grant 8,288,356 - Obad , et al. October 16, 2
2012-10-16
Pharmaceutical Composition Comprising Anti-miRNA Antisense Oligonucleotides
App 20120238618 - Elmen; Joacim ;   et al.
2012-09-20
RNA antagonist compounds for the modulation of HER3
Grant 8,268,793 - Hedtjarn September 18, 2
2012-09-18
Synthesis Of Locked Nucleic Acid Derivatives
App 20120165514 - Sorensen; Mads Detlef ;   et al.
2012-06-28
Oligomeric compounds for the modulation of HIF-1.alpha. expression
Grant 8,207,140 - Thrue , et al. June 26, 2
2012-06-26
Micro-RNA Mediated Modulation of Colony Stimulating Factors
App 20120115924 - Worm; Jesper ;   et al.
2012-05-10
LNA oligonucleotides and the treatment of cancer
Grant 8,173,428 - Rosenbohm , et al. May 8, 2
2012-05-08
Pharmaceutical composition comprising anti-mirna antisense oligonucleotide
Grant 8,163,708 - Elmen , et al. April 24, 2
2012-04-24
Oligomeric Compounds For The Modulation Of Survivin Expression
App 20120088907 - Hansen; Bo ;   et al.
2012-04-12
Pharmaceutical Composition
App 20120083596 - Elmen; Joacim ;   et al.
2012-04-05
Methods Of Treating Cancers With Her3 Antisense Oligonucleotides
App 20120076781 - Zhang; Yixian ;   et al.
2012-03-29
Splice Switching Oligomers for TNF Superfamily Receptors and Their Use in Treatment of Disease
App 20120040917 - ORUM; HENRIK ;   et al.
2012-02-16
Compounds For The Modulation Of Beta-catenin Expression
App 20120004288 - WORM; Jesper
2012-01-05
Lna Antagonists Targeting The Androgen Receptor
App 20110319471 - WORM; Jesper
2011-12-29
Synthesis of locked nucleic acid derivatives
Grant 8,084,458 - Sorensen , et al. December 27, 2
2011-12-27
Compounds for the modulation of beta-catenin expression
Grant 8,039,446 - Worm October 18, 2
2011-10-18
Oligomeric compounds for the modulation of survivin expression
Grant 8,026,355 - Hansen , et al. September 27, 2
2011-09-27
LNA antagonists targeting the androgen receptor
Grant 7,989,429 - Worm August 2, 2
2011-08-02
Potent LNA oligonucleotides for the inhibition of HIF-1a expression
Grant 7,939,507 - Westergaard , et al. May 10, 2
2011-05-10
Compounds For The Modulation Of Beta-catenin Expression
App 20110086902 - WORM; Jesper
2011-04-14
Pharmaceutical Compositions for Treatment of MicroRNA Related Diseases
App 20110077288 - Kauppinen; Sakari ;   et al.
2011-03-31
Compounds for the modulation of beta-catenin expression
Grant 7,915,401 - Worm March 29, 2
2011-03-29
RNA antagonist compounds for the modulation of PIK3CA expression
Grant 7,863,437 - Hedtjarn January 4, 2
2011-01-04
RNA Antagonist Compounds for the Modulation of MCL-1
App 20100323967 - Hansen; Jens Bo Rode ;   et al.
2010-12-23
Oligomeric compounds for the modulation of HIF-1alpha expression
Grant 7,846,911 - Thrue , et al. December 7, 2
2010-12-07
MICROMIRs
App 20100298410 - Obad; Susana ;   et al.
2010-11-25
Combination Treatment For The Treatment of Hepatitis C Virus Infection
App 20100280099 - Elmen; Joacim
2010-11-04
RNA Antagonist Compounds for the Inhibition of Apo-B100 Expression
App 20100227914 - Hansen; Henrik Frydenlund ;   et al.
2010-09-09
Soluble TNF receptors and their use in treatment of disease
Grant 7,785,834 - Sazani , et al. August 31, 2
2010-08-31
Short RNA Antagonist Compounds for the Modulation of Target mRNA
App 20100210712 - Hansen; Jens Bo Rode ;   et al.
2010-08-19
Oligomeric compounds for the modulation of survivin expression
Grant 7,741,309 - Hansen , et al. June 22, 2
2010-06-22
LNA antagonists targeting the androgen receptor
Grant 7,737,125 - Worm June 15, 2
2010-06-15
Oligomeric compounds for the modulation HIF-1.alpha. expression
Grant 7,737,264 - Thrue , et al. June 15, 2
2010-06-15
Oligomeric compounds for the modulation of survivin expression
Grant 7,713,738 - Hansen , et al. May 11, 2
2010-05-11
Oligonucleotides with alternating segments of locked and non-locked nucleotides
Grant 7,687,617 - Thrue , et al. March 30, 2
2010-03-30
Adenosine Receptor Antagonists
App 20100062994 - Ravn; Jacob ;   et al.
2010-03-11
Pharmaceutical Composition
App 20100004320 - Elmen; Joacim ;   et al.
2010-01-07
Pharmaceutical compositions for treatment of microRNA related diseases
App 20090298916 - Kauppinen; Sakari ;   et al.
2009-12-03
Oligomeric compounds for the modulation of Bcl-2
Grant 7,622,453 - Frieden , et al. November 24, 2
2009-11-24
Splice Switching Oligomers for TNF Superfamily Receptors and their Use in Treatment of Disease
App 20090264353 - Orum; Henrik ;   et al.
2009-10-22
Potent LNA oligonucleotides for the inhibition of HIF-1A expression
Grant 7,589,190 - Westergaard , et al. September 15, 2
2009-09-15
Oligonucleotides With Alternating Segments Of Locked And Non-locked Nucleotides
App 20090209748 - Thrue; Charlotte Albaek ;   et al.
2009-08-20
Compounds For The Modulation Of Beta-catenin Expression
App 20090203137 - Worm; Jesper
2009-08-13
Synthesis of locked nucleic acid derivatives
Grant 7,569,575 - Sorensen , et al. August 4, 2
2009-08-04
Rna Antagonist Compounds For The Modulation Of Pik3ca Expression
App 20090192110 - Hedtjarn; Maj
2009-07-30
Lna Oligonucleotides And The Treatment Of Cancer
App 20090181914 - ROSENBOHM; CHRISTOPH ;   et al.
2009-07-16
MICROMIRs
App 20090143326 - Obad; Susanna ;   et al.
2009-06-04
Compounds For The Modulation Of Beta-catenin Expression
App 20090005335 - Worm; Jesper
2009-01-01
Rna Antagonist Compounds For The Modulation Of Her3
App 20080318894 - Hedtjarn; Maj
2008-12-25
Modified Short Interfering Rna (Modified Sirna)
App 20080249039 - Elmen; Joacim ;   et al.
2008-10-09
Short interfering rna (sirna) analogues
App 20070191294 - Elmen; Joacim ;   et al.
2007-08-16
Method for preparation of LNA phosphoramidites
Grant 7,153,954 - Koch , et al. December 26, 2
2006-12-26
Potent LNA oligonucleotides for the inhibition of HIF-1a expression
App 20060252721 - Westergaard; Majken ;   et al.
2006-11-09
LNA oligonucleotides and the treatment of cancer
App 20060154888 - Rosenbohm; Christoph ;   et al.
2006-07-13
Antisense design
App 20060128646 - Christensen; Signe M. ;   et al.
2006-06-15
Synthesis of purine locked nucleic acid analogues
Grant 6,998,484 - Koch , et al. February 14, 2
2006-02-14
Oligomeric compounds for the modulation of Bcl-2
App 20050203042 - Frieden, Miriam ;   et al.
2005-09-15
Synthesis of allofuranose
Grant 6,858,726 - Koch , et al. February 22, 2
2005-02-22
Oligomeric compounds for the modulation of ras expression
App 20040248840 - Hansen, Bo ;   et al.
2004-12-09
Oligomeric compounds for the modulation of thioredoxin expression
App 20040241717 - Hansen, Bo ;   et al.
2004-12-02
Company Registrations
SEC0001607648SANTARIS PHARMA A/S

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed